PDL BioPharma, Inc. Long-Term Debt, Maturity, Year Four
PDL BioPharma, Inc. had Long-Term Debt, Maturity, Year Four of $0 as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2021-03-29
- 2020-12-31: Long-Term Debt, Maturity, Year Four $0.00.
- 2019-12-31: Long-Term Debt, Maturity, Year Four $0.00.
- 2018-12-31: Long-Term Debt, Maturity, Year Four $0.00.
- 2017-12-31: Long-Term Debt, Maturity, Year Four $150.00M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 |
| 2019-12-31 | $0.00 8-K · filed 2020-06-29 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2017-12-31 | $150.00M 10-K · filed 2018-03-16 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2011-12-31 | $335.25M 10-K · filed 2012-02-23 |